Evidence map›Paper›PMID 33093963›Full record

ArticleJournal of pharmaceutical policy and practice2020

Needs assessment and impact of COVID-19 on pharmacy professionals in 31 commonwealth countries.

Diane Ashiru-Oredope, Amy Hai Yan Chan, Omotayo Olaoye, Victoria Rutter, Zaheer-Ud-Din Babar, C. P. A. COVID-19 Action Team

Open access · goldAbstract read
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Global Healthcare Needs Related to COVID-19: An Evidence Map of the First Year of the Pandemic.International journal of environmental research and public health · 2022
    Review
  5. Article
  6. Article
  7. Development of Metal Complexes for Treatment of Coronaviruses.International journal of molecular sciences · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. The Particularities of Pharmaceutical Care in Improving Public Health Service during the COVID-19 Pandemic.International journal of environmental research and public health · 2021
    Review
  12. Article
  13. Review
  14. Article
  15. Pharmacy response to COVID-19: lessons learnt from Canada.Journal of pharmaceutical policy and practice · 2020
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Diane Ashiru-OredopeCommonwealth Pharmacists Association, London, UK.ORCID 0000-0001-9579-2028
Amy Hai Yan ChanCommonwealth Pharmacists Association, London, UK.
Omotayo OlaoyeCommonwealth Pharmacists Association, London, UK.
Victoria RutterCommonwealth Pharmacists Association, London, UK.
Zaheer-Ud-Din BabarDepartment of Pharmacy, University of Huddersfield, Queensgate, Huddersfield, HD1 3DH UK.
C. P. A. COVID-19 Action Team
University of Auckland · NZUniversity of Huddersfield · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe declaration of COVID-19 a pandemic by the World Health Organization on 11 March 2020 marked the beginning of a global health crisis of an unprecedented nature and scale. The approach taken by countries across the world varied widely, however, the delivery of frontline healthcare was consistently recognised as being central to the pandemic response. This study aimed to identify and explore the issues currently facing pharmacy teams across Commonwealth countries during the COVID-19 pandemic. The study also evaluates pharmacy professionals' understanding of key knowledge areas from the COVID-19 webinar hosted by the Commonwealth Pharmacists' Association (CPA).

methodA quantitative survey-based approach was adopted, using a 32-item questionnaire developed from the literature on pharmacy and pandemic response. The survey was hosted on Survey Monkey and pilot tested. The final survey was disseminated by CPA member organisations. A 6-item online questionnaire was sent via email to all attendees of CPA's COVID-19 webinar. Descriptive statistics on frequency distributions and percentages were used to analyse the responses. Data were analysed using Microsoft

resultsThere were 545 responses from pharmacy professionals across 31/54 Commonwealth countries in Africa, Asia, the Americas, Europe and the Pacific. Majority of the respondents reported being at least somewhat worried (90%) and more than 65% were very worried or extremely about the impact of COVID-19 on them personally and professionally. Nearly two-thirds of respondents stated finding it somewhat difficult or very difficult to work effectively during the pandemic. Challenges mostly faced by pharmacy professionals working remotely included; general anxiety about the impact of COVID-19 on their lives (12%), and difficulties in communicating with their co-workers (12%). Most pharmacy professionals had not previously been actively involved in a global health emergency (82%) nor obtained training on global/public health emergency preparedness (62%). Between 45 and 97% of the COVID-19 webinar attendees provided the correct answers to post-webinar questions, suggesting some improvement in knowledge.

conclusionOur study confirms pharmacy professionals' concerns about practice during a pandemic and provides preliminary data on the challenges and learning needs of the profession. The CPA has since acted on these findings, providing ongoing opportunities to develop and refine resources for the profession as the pandemic evolves. Pharmacy professionals have also demonstrated improved knowledge on the management of COVID-19 and resources available for professionals.

Indexed as

CHOGMCommonwealthCoronavirusCOVID-19CPACwPAMSEmergency preparednessHeads of GovernmentHealthPandemicPharmacistsPharmacy

Identifiers

PMID33093963
PMCPMC7576098
OpenAlexW3094503552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.